Skip to main content Deutsch

Publikationen

Comprehensive Cancer Center Wien
Sorry, this content is only available in German!

Vom CCC unterstützte Publikationen 2022

Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review

Melanie Hassler, Urologie

Rebhan, K., Wasinger, G., Hassler, M. R., Shariat, S. F., & Compérat, E. M. (2022). Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. Current opinion in urology, 32(4), 358–363. doi.org/10.1097/MOU.0000000000001007

Nonmuscle-invasive bladder cancer, old problems, new insights

Eva Compérat, Pathologie

Compérat, E., Wasinger, G., Oszwald, A., Pradere, B., & Shariat, S. (2022). Nonmuscle-invasive bladder cancer, old problems, new insights. Current opinion in urology, 32(4), 352–357. doi.org/10.1097/MOU.0000000000000997

Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update

Shahrokh Shariat, Urologie

Vartolomei, M. D., Ferro, M., Roth, B., Teoh, J. Y., Gontero, P., & Shariat, S. F. (2022). Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. Current opinion in urology, 10.1097/MOU.0000000000001010. Advance online publication. doi.org/10.1097/MOU.0000000000001010

International Alliance of Urolithiasis (IAU) Guideline on Retrograde Intrarenal Surgery

Christian Seitz, Urologie

Zeng, G., Traxer, O., Zhong, W., Osther, P., Pearle, M. S., Preminger, G. M., Mazzon, G., Seitz, C., Geavlete, P., Fiori, C., Ghani, K. R., Chew, B. H., Git, K. A., Vicentini, F. C., Papatsoris, A., Brehmer, M., Martinez, J. L., Cheng, J., Cheng, F., Gao, X., … Sarica, K. (2022). International Alliance of Urolithiasis (IAU) Guideline on Retrograde Intrarenal Surgery. BJU international, 10.1111/bju.15836. Advance online publication. doi.org/10.1111/bju.15836

Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program

Konrad Hoetzendecker, Thoraxchirurgie

Kerpel-Fronius, A., Monostori, Z., Kovacs, G., Ostoros, G., Horvath, I., Solymosi, D., Pipek, O., Szatmari, F., Kovacs, A., Markoczy, Z., Rojko, L., Renyi-Vamos, F., Hoetzenecker, K., Bogos, K., Megyesfalvi, Z., & Dome, B. (2022). Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program. European radiology, 32(7), 4457–4467. doi.org/10.1007/s00330-022-08589-7

Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis

Foto von Karin Schelch
Karin Schelch, Zentrum für Krebsforschung

Lang, C., Egger, F., Alireza Hoda, M., Saeed Querner, A., Ferencz, B., Lungu, V., Szegedi, R., Bogyo, L., Torok, K., Oberndorfer, F., Klikovits, T., Schwendenwein, A., Boettiger, K., Renyi-Vamos, F., Hoetzenecker, K., Schelch, K., Megyesfalvi, Z., & Dome, B. (2022). Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis. Lung cancer (Amsterdam, Netherlands), 169, 40–46. doi.org/10.1016/j.lungcan.2022.05.010

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry

Martin Filipits, Zentrum für Krebsforschung

Singer, C. F., Jahn, S. W., Rudas, M., Bago-Horvath, Z., Fitzal, F., Abete, L., Moinfar, F., Gnant, M., Filipits, M., & Austrian Breast and Colorectal Cancer Study Group (ABCSG) (2022). Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry. Breast (Edinburgh, Scotland), 64, 127–133. Advance online publication. doi.org/10.1016/j.breast.2022.05.003

The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study

Florian Fitzal, Allgemeinchirurgie

Bolliger, M., Lanmüller, P., Schuetz, M., Heilig, B., Windischbauer, A., Jakesz, R., Zehetgruber, T., Gnant, M., Gleiss, A., Dörfler, D., Singer, C., Bartsch, R., Haslik, W., Montagna, G., & Fitzal, F. (2022). The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cance - A prospective, controlled, single-center study. International journal of surgery (London, England), 106694. Advance online publication. https://doi.org/10.1016/j.ijsu.2022.106694

Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy

Foto von Shahrokh Shariat
Shahrokh Shariat, Urologie

Hoeh, B., Flammia, R. S., Hohenhorst, L., Sorce, G., Panunzio, A., Chierigo, F., Nimer, N., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Shariat, S. F., Graefen, M., Tilki, D., Antonelli, A., Terrone, C., Kluth, L. A., Becker, A., Chun, F., & Karakiewicz, P. I. (2022). Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. Surgical oncology, 42, 101783. doi.org/10.1016/j.suronc.2022.101783

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and ... (EFC) consensus statement on pre-invasive vulvar lesions

Elmar Joura, Frauenheilkunde

Preti, M., Joura, E., Vieira-Baptista, P., Van Beurden, M., Bevilacqua, F., Bleeker, M., Bornstein, J., Carcopino, X., Chargari, C., Cruickshank, M. E., Erzeneoglu, B. E., Gallio, N., Heller, D., Kesic, V., Reich, O., Stockdale, C. K., Esat Temiz, B., Woelber, L., Planchamp, F., Zodzika, J., … Gultekin, M. (2022). The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, ijgc-2021-003262. Advance online publication. doi.org/10.1136/ijgc-2021-003262

Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy

Foto Joanna Loizou
Joanna Loizou, Zentrum für Krebsforschung

Moretton, A., Slyskova, J., Simaan, M. E., Arasa-Verge, E. A., Meyenberg, M., Cerrón-Infantes, D. A., Unterlass, M. M., & Loizou, J. I. (2022). Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy. Frontiers in oncology, 12, 874201. doi.org/10.3389/fonc.2022.874201

Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis

Shahrokh Shariat, Urologie

Kawada, T., Yanagisawa, T., Rajwa, P., Sari Motlagh, R., Mostafaei, H., Quhal, F., Laukhtina, E., Aydh, A., König, F., Pallauf, M., Pradere, B., Ceci, F., Baltzer, P., Hacker, M., Rasul, S., Karakiewicz, P. I., Araki, M., Nasu, Y., & Shariat, S. F. (2022). Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. European urology oncology, S2588-9311(22)00064-5. Advance online publication. https://doi.org/10.1016/j.euo.2022.04.006

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel

Rupert Bartsch, Innere Medizin I

Arboleda, B., Bartsch, R., de Azambuja, E., Hamilton, E., Harbeck, N., Klemp, J., Knauer, M., Kuemmel, S., Mahtani, R., Schwartzberg, L., Villarreal-Garza, C., & Wolff, A. (2022). Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel. The oncologist, oyac101. Advance online publication. https://doi.org/10.1093/oncolo/oyac101

Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer

Shahrokh Shariat, Urologie

Afferi, L., Lonati, C., Montorsi, F., Briganti, A., Necchi, A., Mari, A., Minervini, A., Tellini, R., Campi, R., Schulz, G. B., Black, P. C., di Trapani, E., de Cobelli, O., Karnes, R. J., Ahmed, M., Mir, M. C., Algarra, M. A., Rink, M., Zamboni, S., Mondini, F., … European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group (2022). Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. European urology oncology, S2588-9311(22)00062-1. Advance online publication. https://doi.org/10.1016/j.euo.2022.04.001

Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas

Ulrich Jäger, Innere Medizin I

Ghilardi, G., Chong, E. A., Svoboda, J., Wohlfarth, P., Nasta, S. D., Williamson, S., Landsburg, J. D., Gerson, J. N., Barta, S. K., Pajarillo, R., Myers, J., Chen, A. I., Schachter, L., Yelton, R., Ballard, H. J., Hodges Dwinal, A., Gier, S., Victoriano, D., Weber, E., Napier, E., … Schuster, S. J. (2022). Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, S0923-7534(22)01722-7. Advance online publication. doi.org/10.1016/j.annonc.2022.05.521

Neoadjuvant Immunotherapy in Gastrointestinal Cancers - The New Standard of Care?

Michael Bergmann, Allgemeinchirurgie

Petricevic, B., Kabiljo, J., Zirnbauer, R., Walczak, H., Laengle, J., & Bergmann, M. (2022). Neoadjuvant Immunotherapy in Gastrointestinal Cancers - The New Standard of Care?. Seminars in cancer biology, S1044-579X(22)00126-2. Advance online publication. https://doi.org/10.1016/j.semcancer.2022.05.015

Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score

Foto von Cihan Ay
Cihan Ay, Innere Medizin I

de Winter, M. A., Dorresteijn, J., Ageno, W., Ay, C., Beyer-Westendorf, J., Coppens, M., Klok, F. A., Moustafa, F., Riva, N., Ruiz Artacho, P. C., Vanassche, T., & Nijkeuter, M. (2022). Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score. Thrombosis and haemostasis, 122(5), 818–829. doi.org/10.1055/s-0041-1735251

Unanswered questions in cancer-associated thrombosis

Foto von Cihan Ay
Cihan Ay, Innere Medizin I

Sanfilippo, K. M., Moik, F., Candeloro, M., Ay, C., Di Nisio, M., & Lee, A. (2022). Unanswered questions in cancer-associated thrombosis. British journal of haematology, 10.1111/bjh.18276. Advance online publication. https://doi.org/10.1111/bjh.18276

Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Christian Singer, Frauenheilkunde

Gampenrieder, S. P., Pircher, M., Fesl, C., Rinnerthaler, G., Mlineritsch, B., Greil-Ressler, S., Steger, G. G., Sagaster, V., Fitzal, F., Exner, R., Devyatko, Y., Balic, M., Stöger, H., Suppan, C., Bauernhofer, T., Singer, C. F., Pfeiler, G., Seifert, M., Helfgott, R., Heck, D., … Greil, R. (2022). Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Breast care (Basel, Switzerland), 17(2), 137–145. doi.org/10.1159/000516157

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.

Portraitfoto von Prager, G. W.
Prager, G. W., Innere Medizin I

Taghizadeh H, Maj-Hes A, Prager GW, Müllauer L, Mader RM. Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors. Cancers (Basel). 2022 Apr 12;14(8):1936. doi.org/10.3390/cancers14081936 PMID: 35454843; PMCID: PMC9032789.

Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study

Foto von Univ.-Prof. Dr. Joachim Widder Leiter des Comprehensive Cancer Center und Leiter der Universitätsklinik für Radioonkologie
Joachim Widder, Radioonkologie

Sinn, K., Mosleh, B., Steindl, A., Zoechbauer-Mueller, S., Dieckmann, K., Widder, J. ,Steiner, E., Klepetko, W., Hoetzenecker, K., Laszlo, V., Doeme, B., Klikovits, T., & Hoda, M. A. (2022). Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study. ESMO open, 7(2), 100466. https://doi.org/10.1016/j.esmoop.2022.100466